For Investors

Welcome to Sathgen Therapeutics:  Thank you for your interest in Sathgen Therapeutics, a biotech company dedicated to developing innovative cancer therapies.

Our Mission: Our mission is to develop breakthrough therapies for cancer patients and improve their quality of life. We are committed to making a positive impact on healthcare.

Why Invest in Sathgen Therapeutics: Sathgen Therapeutics is a promising investment opportunity for several reasons. Our lead compound has shown in vitro and in vivo efficacy against triple negative breast cancer and prostate cancer, with a good safety profile. We have a rich pipeline of over 15 compounds in preclinical development, targeting a variety of cancers. We have strong financial support from our parent company, Godavari Biorefineries Limited, and our technical partner, Clinexel, has expertise in early-stage clinical development and global clinical development capabilities. Investing in Sathgen Therapeutics provides  the opportunity to support a company that is dedicated to making a positive impact on healthcare while potentially achieving financial returns.

How to Invest: If you are interested in investing in Sathgen Therapeutics, please contact us to learn more.